![](/img/cover-not-exists.png)
High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801
Kirkwood, John M., Ibrahim, Joseph G., Sosman, Jeffrey A., Sondak, Vernon K., Agarwala, Sanjiv S., Ernstoff, Marc S., Rao, UmaVolume:
19
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2001.19.9.2370
Date:
May, 2001
File:
PDF, 109 KB
2001